STAT

Opinion: The polar vortex exposed a major flaw in our volunteer blood supply system

Growing platelets from stem cells and finding better ways to store them could help complement blood drives for this essential and perishable blood component.
The polar vortex froze out residents in much the U.S. in January, including in Chicago above, and it exposed a major flaw in the country's volunteer blood supply system.

When the polar vortex froze out residents in much the United States in January, it also sent chills through the U.S. blood system, especially for people who needed platelets.

“If you are safely able to leave your house, please consider giving blood for hospital patients,” tweeted the Red Cross of Massachusetts. “Polar vortex blamed for critically low blood supply,” reported Minnesota’s Northwest Community Television.

The record cold exposed a key problem underlying our nation’s blood donation system. It relies exclusively on volunteer donors to provide blood for transfusion. But bad weather routinely keeps potential donors away

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks